Performance-based Innovation Rewards

Projektinformationen

REWARD

ID Finanzhilfevereinbarung: 339239

Abgeschlossenes Projekt

Startdatum 1 Februar 2014

Enddatum 31 Januar 2019

Finanziert unter

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 1 922 338,40

EU-Beitrag € 1 922 338,40

Koordiniert durch

UNIVERSITY OF CENTRAL LANCASHIRE
United Kingdom

Ziel

REWARD will open up new horizons in complementing the international intellectual property rights (IPR) system. The project's ambitious output is an ethically and legally sound performance-based reward mechanism for pharmaceutical innovation, which complements the existing patent regime, yet mitigates its considerable disadvantages for the global poor.

The current IPR system impedes access to life-saving medicines for the poor in two main ways. First, high prices for pharmaceutical innovations are required to recoup research and development costs through time-limited patent protection. Whilst high price levels maintain incentives for pharmaceutical innovation, they price new medicines beyond the range of the poor creating an accessibility problem. At the same time, diseases that burden the poor are often not worthy of investment for pharmaceutical innovators, creating an availability problem ('neglected diseases').

Many international research groups are working on IPR reform plans based on performance-based rewards for pharmaceutical innovation. However, their efforts are disparate and lacking a guiding vision. REWARD will use world-class ethics research as the steering force to determine which performance-based reward mechanism for pharmaceutical innovation is the most promising. In an interdisciplinary collaboration of ethicists, lawyers, economists, and statisticians, with experts in medicine, science and technology policy and gender studies the selected mechanism will be tested in a developed and a developing country.

Wissenschaftliches Gebiet

• social sciences › sociology › gender studies
• social sciences › economics and business › business and management › innovation management
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs

Programm/Programme

• FP7-IDEAS-ERC - Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Thema/Themen

• ERC-AG-SH2 - ERC Advanced Grant - Institutions, values, beliefs and behaviour

Aufforderung zur Vorschlagseinreichung

ERC-2013-ADG
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

ERC-AG - ERC Advanced Grant

Gastgebende Einrichtung

UNIVERSITY OF CENTRAL LANCASHIRE

Kontakt Verwaltung

Alexis Holden (Dr.)

Hauptforscher

Thomas Winfried Menko Pogge (Prof.)

• EU-Beitrag: € 1 464 968,00
• Adresse: - ; PR1 2HE Preston ; Vereinigtes Königreich
• Region: North West (England) › Lancashire › Mid Lancashire
• Aktivitätstyp: Higher or Secondary Education Establishments
• Gesamtkosten: Keine Daten

Begünstigte (3)

UNIVERSITY OF CENTRAL LANCASHIRE

Vereinigtes Königreich

Kontakt Verwaltung

Alexis Holden (Dr.)

Hauptforscher

Thomas Winfried Menko Pogge (Prof.)

• EU-Beitrag: € 1 464 968,00
• Adresse: - ; PR1 2HE Preston
• Region: North West (England) › Lancashire › Mid Lancashire
• Aktivitätstyp: Higher or Secondary Education Establishments
• Gesamtkosten: Keine Daten

RESEARCH AND INFORMATION SYSTEM FOR DEVELOPING COUNTRIES

Indien

Kontakt Verwaltung

Sachin Chaturvedi (Dr.)

• EU-Beitrag: € 217 327,20
• Adresse: LODHI ROAD, INDIA HABITAT CENTRE, CORE 4B 4th FLOOR ; 110 003 New Delhi
• Aktivitätstyp: Research Organisations
• Gesamtkosten: Keine Daten

University of Calgary

Kanada

Kontakt Verwaltung

John Reynolds (Dr.)

• EU-Beitrag: € 240 043,20
• Adresse: University Drive NW 2500 ; T2N 1N4 Calgary Alberta
• Aktivitätstyp: Higher or Secondary Education Establishments
• Gesamtkosten: Keine Daten